Faculty Opinions recommendation of Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2-4 COPD: results from two replicate 48-week studies.
2010 ◽
Vol 33
(2)
◽
pp. 213-224
◽
Keyword(s):
1996 ◽
Vol 27
(2)
◽
pp. 131
Keyword(s):
Keyword(s):
2021 ◽
Vol 85
(3)
◽
pp. AB155
1992 ◽
Vol 4
(6)
◽
pp. 358-363
◽